Keywords: Biosimilars, Automatic substitution, USA, Europe, Physicians views, Insulin, Decision Resources

Most US and European physicians believe automatic substitution of biosimilars is a bad idea

Article | 05 September 2012

Specialist physicians surveyed in the USA and Europe are generally opposed to pharmacy-level automatic substitution of branded biologics for biosimilars, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in